Cargando…

The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer

Prostate cancer (PCa) has a high prevalence and represents an important health problem, with an increased risk of metastasis. With the advance of CRISPR-Cas9 genome editing, new possibilities have been created for investigating PCa. The technique is effective in knockout oncogenes, reducing tumor re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camargo, Juliana A., Viana, Nayara I., Pimenta, Ruan, Guimarães, Vanessa R., dos Santos, Gabriel A., Candido, Patrícia, Ghazarian, Vitória, Romão, Poliana, Silva, Iran A., Birbrair, Alexander, Srougi, Miguel, Nahas, William C., Leite, Kátia R., Trarbach, Ericka B., Reis, Sabrina T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573678/ https://www.ncbi.nlm.nih.gov/pubmed/37834295 http://dx.doi.org/10.3390/ijms241914847

Ejemplares similares

Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer
por: Pimenta, Ruan, et al.
Publicado: (2023)

Tissue expression of MMP-9, TIMP-1, RECK, and miR338-3p in prostate gland: can it predict cancer?
por: de Moraes, Rodolfo Pacheco, et al.
Publicado: (2021)

MMP9 overexpression is associated with good surgical outcome in children with UPJO: Preliminary results
por: Reis, Sabrina Thalita, et al.
Publicado: (2016)

Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
por: dos Santos, Gabriel Arantes, et al.
Publicado: (2021)

miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression
por: Ivanovic, Renato F., et al.
Publicado: (2018)

MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19
por: Pimenta, Ruan, et al.
Publicado: (2021)

Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
por: Reis, Sabrina Thalita, et al.
Publicado: (2012)

Combined spinal and general anesthesia attenuate tumor promoting effects of surgery. An experimental animal study
por: Inoue, Gustavo N.C., et al.
Publicado: (2022)

Can we use Ki67 expression to predict prostate cancer aggressiveness?
por: MAIA, RONALDO, et al.
Publicado: (2022)

MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma
por: Falzone, Luca, et al.
Publicado: (2016)

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer
por: Ivanovic, Renato F., et al.
Publicado: (2018)

The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer
por: Reis, Sabrina T., et al.
Publicado: (2013)

Polymorphism in the PBX1 gene is related to cystinuria in Brazilian families
por: Reis, Sabrina T., et al.
Publicado: (2018)

MicroRNA 100: a context dependent miRNA in prostate cancer
por: Leite, Katia R. M., et al.
Publicado: (2013)

Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer
por: Leite, Katia R. M., et al.
Publicado: (2015)

Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
por: Piantino, Camila B., et al.
Publicado: (2013)

The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability
por: Morais, Denis R, et al.
Publicado: (2014)

Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer
por: Katz, Betina, et al.
Publicado: (2014)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
por: Huang, Hao
Publicado: (2018)

The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
por: Li, Zhenshengnan, et al.
Publicado: (2023)

Expression of MMP-2 and MMP-9 in the rat trigeminal ganglion during the development of temporomandibular joint inflammation
por: Nascimento, G.C., et al.
Publicado: (2013)

Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer
por: dos Reis, Sabrina Thalita, et al.
Publicado: (2015)

Detection and activity of MMP-2 and MMP-9 in Leishmania amazonensis and Leishmania braziliensis promastigotes
por: Costa, Brenda Furtado, et al.
Publicado: (2023)

MMP2 and MMP9 associate with crescentic glomerulonephritis
por: Phillips, Tessa M., et al.
Publicado: (2017)

Structural characterisation of inhibitory and non-inhibitory MMP-9–TIMP-1 complexes and implications for regulatory mechanisms of MMP-9
por: Charzewski, Łukasz, et al.
Publicado: (2021)

MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease
por: Medeiros, Nayara I., et al.
Publicado: (2019)

Potential of MMP-9 based nanoparticles at optimizing the cow dry period: pulling apart the effects of MMP-9 and nanoparticles
por: Gifre-Renom, L., et al.
Publicado: (2020)

Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer
por: Reis, Sabrina T., et al.
Publicado: (2016)

Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
por: Oliveira, Rita de Cássia, et al.
Publicado: (2017)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma
por: Su, Gao-Jian, et al.
Publicado: (2022)

Matrix Metalloproteinase-2 (MMP-2) and-9 (MMP-9) Gene Variants and Microvascular Complications in Type 2 Diabetes Patients
por: Andjelic, Jelic M, et al.
Publicado: (2023)

Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody
por: Velasquez, Maile, et al.
Publicado: (2023)

The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity
por: Dimic-Janjic, Sanja, et al.
Publicado: (2023)

Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias
por: Bouchet, Sandrine, et al.
Publicado: (2014)

Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997)

Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients
por: Buraczynska, Kinga, et al.
Publicado: (2015)

Computational design of Matrix Metalloprotenaise-9 (MMP-9) resistant to autocleavage
por: Bonadio, Alessandro, et al.
Publicado: (2023)

Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment
por: Rashid, Zainab Ahmed, et al.
Publicado: (2023)

Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
por: Kofla-Dlubacz, Anna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_214924e53hiiphdtf8ub3i3qdl